ICosentyx: yenzelwe ini nokuthi uyithatha kanjani

-Delile

• Yenzelwe ini
• Isetshenziswa kanjani
• 1. I-plaque psoriasis
• 2. Isifo samathambo se-Psoriatic
• 3. I-Ankylosing spondylitis
• Imiphumela emibi engaba khona
• Ngubani ongafanele asebenzise

ICosentyx ngumuthi ojojwayo one-secuquinumab ekwakhekeni kwayo, okusetshenziswa kwezinye izimo ze-plaque psoriasis elinganiselayo noma ebucayi ukuvimbela ukubonakala kokushintshwa kwesikhumba nezimpawu ezinjengokulunywa noma ukuqhuma.

Lo muthi ukwakhiwa kwawo une-antibody yomuntu, i-IgG1, ekwazi ukuvimbela ukusebenza kweprotheni ye-IL-17A, ebhekele ukwakheka kwamapuleti ezimweni ze-psoriasis.

Yenzelwe ini

ICosentyx ikhonjisiwe ekwelapheni i-plaque psoriasis elinganiselayo kuya kwabanzima kubantu abadala abafuna ukhetho lwe-systemic therapy noma i-phototherapy.

Isetshenziswa kanjani

Indlela iCosentyx esetshenziswa ngayo iyahlukahluka ngokuya ngesiguli nohlobo lwe-psoriasis futhi, ngakho-ke, kufanele iholwe njalo ngudokotela onolwazi nokwelashwa kwe-psoriasis.

1. I-plaque psoriasis

Umthamo onconywayo ngu-300 mg, olingana nemijovo emibili engaphansi kwe-150 mg, ngokulawulwa kokuqala emasontweni 0, 1, 2, 3 no-4, kulandelwe ukuphathwa kokugcinwa kwanyanga zonke.

2. Isifo samathambo se-Psoriatic

Umthamo onconywayo kubantu abane-psoriatic arthritis ngu-150 mg, nge-injection engaphansi, ngokulawulwa kokuqala emasontweni 0, 1, 2, 3 no-4, kulandelwa ukuphathwa kokugcinwa kwanyanga zonke.

Kubantu abanempendulo enganele kwi-anti-TNF-alpha noma nge-concomitant moderation to kali plaque psoriasis, umthamo onconyiwe ngu-300 mg, onikezwa njengemijovo emibili engaphansi kwe-150 mg, ngokuphathwa kokuqala emasontweni 0, 1, 2, 3 kanye 4, kulandelwe ukuphathwa kwesondlo sanyanga zonke.

3. I-Ankylosing spondylitis

Kubantu abane-ankylosing spondylitis, umthamo ophakanyisiwe yi-150 mg, elawulwa ngomjovo ongaphansi, ngokulawulwa kokuqala emasontweni 0, 1, 2, 3 no-4, kulandelwe ukuphathwa kokugcinwa kwanyanga zonke.

Ezigulini okungekho kuzo ukuthuthuka kwezimpawu kuze kube amasonto ayi-16, kunconywa ukuyeka ukwelashwa.

Imiphumela emibi engaba khona

Imiphumela emibi kakhulu engenzeka ngesikhathi sokwelashwa izifo ezithathelwanayo zokuphefumula ezinomphimbo obuhlungu noma ikhala eligcwele, i-thrush, isifo sohudo, isifuba nekhala eligijimayo.

Uma umuntu enenkinga yokuphefumula noma ukugwinya, kukhona ukuvuvukala kobuso, izindebe, ulimi noma umphimbo noma ukulunywa okukhulu kwesikhumba, ngokuqubuka okubomvu noma ukuvuvukala, kufanele uye kudokotela ngokushesha futhi umise imishanguzo.

Ngubani ongafanele asebenzise

ICosentyx iyaphikiswa kwiziguli ezinokutheleleka okunamandla, njengesifo sofuba, isibonelo, kanye neziguli ezine-hypersensitivity to secuquinumab noma enye into ekhona kwifomula.